A B S T R A C T The possible physiological imiiportainee of the groups of insulin receptors on rat adipocytes and the relationship of these groups to insulin action were investigated. The effect of cytochalasin B aind D on l)iological actions of insulin was measured aind coimipared with the effect of these agents on the ultrastructural distribution of groups of insulin receptors. Cytochalasin B had no effect on epinephrine-stimulated lipolysis, insulin inhibition of epinephrine-stimulated lipolysis, or insulin stimulation of protein synthesis. Cytochalasin B, over a concentration rainge of 50 nM to 5 ,uM, progressively inhibited the basal glucose transport system, as measured by glucose oxidation, 2-deoxyglucose transport, and 3-O-methylglucose transport. Insulin was capable of fully stimulating remaining basal transport at submaximal concentrations of cytochalasin B. Insulin pretreatment of adipocytes partially protected the glucose transport system from inhibition by cytochalasin B. Cytochalasin B markedly altered the distribution pattern of insulin receptors, which caused an increase in the number of single receptor molecules by decreasing the number of larger groups. A significant correlation (r = 0.964; P < 0.001) was found between the percent increase in single receptors and the percent decrease in glucose transport. Ferritin-insulin pretreatment of adipocytes prevented disruption of the groups of insulin receptors by cytochalasin B. Cytochalasin D had no effect on the biological actions of insulin or on the groups of insulin receptors. These data suggest that the ability of insulin to affect adlipoeyte metabolism is independent of the hormonie occupying adjacent, groupedl receptor sites. The marked contrast in effects of cytochalasin B and D on groups of insulini receptors ancd glucose transport suggests that the microfilaimenit system is not involved in insulin actioni or in holding the groups of insulin receptors together, as both agenits are known disrupters of microfilamenits and inhibitors of actin gelation. The correlation betweeni the effects of cytochalasini B on insulin receptor distribution and glucose transport leads to the speculation that the glycoprotein molecules containiing the insulin receptor are funcetionally linked with the glucose transport systemii.
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INTRODUCTION
It is generally accepted that insulini initially interacts with specific receptors on the plasma membrane of cells. This has been demonstrated by both biochemical (1, 2) and morphological techniques (3) . With ferritininsulin we have shown that the insulin receptors on rat adipocytes are distributed on the surface of the cell associated with the glycocalyx region of the plasma membrane (4) (5) (6) . The receptors were visualized either as single receptors or in groups oftwo to six. The groups were shown to occur before, and independent of, the binding of the hormone to the receptor.
This study attempted to determine the possible physiological importance of these groups of insulin receptors and to determine if they were essential to insulin action. The experimental design was to attempt to disrupt the groups of receptors by a chemical agent and relate this to alterations in the biological responses to insulin. Cytochalasin B was chosen as the pharmacological tool for disrupting the groups of insulin receptors for several reasons. Cytochalasin B is known to disrupt clusters of aggregated receptors (7) and intramembranous particles (8) , possibly through its actions on microfilaments and actin (9) . This agent has been used to inhibit basal and insulin-stimulated glucose transport (10) , but has been shown not to affect numerous other insulin-sensitive processes (11) , including both membrane-localized and intracellular responses. The unaffected membrane processes include aaminoisobutyrate transport and a specific fructose transport system, whereas the unaffected intracellular insulin-sensitive action was the antilipolytic effect of the hormone. Data from this report demonstrate that disruption of groups of insulin receptors by cytochalasin B does not prevent insulin from exerting its action. However, disruption of the groups of insulin receptors correlated with the inhibition of the basal glucose transport system, which suggests that some of the insulin receptors are on the same glycoproteins which form the glucose transport system.
METHODS
Preparation of isolated adipocytes. Adipocytes were prepared as described by Rodbell (12) . Minced epididymal fat pads from 120-g male Wistar rats were incubated in KrebsRinger phosphate buffer containing one-half the normal calcium concentration, 3% bovine serum albumin (BSA),' and 0.2% dextrose with 1 mg crude collagenase per milliliter at pH 7.4. The pads were digested for 40-45 min at 37°C, after which the contents of the digestion flasks were filtered through a silk screen. The cells in the filtrate were centrifuged at 800 g for 30 s, and the infranatant was aspirated. The cells were washed three times by resuspension and centrifugation in Krebs-Ringer phosphate buffer with BSA and dextrose as above. Dextrose was omitted from the washing buffer of cells to be used for glucose oxidation or transport studies. After the final wash, the cells were resuspended in the wash buffer to a concentration of = 106 cells/ml and allowed to equilibrate at 37°C for 15 min before beginning any assay. Protein ineasurements of whole-cell suspensions were determined by performing cell counts as previously described (13) .
Biochemical studies. Adipocyte lipolysis was determined by measuring the amount of glycerol released during a 30-min incubation at 37°C (13) . Triplicate vials were prepared which contained (a) epinephrine (0.125 /ig/ml; (b) cytochalasin B (1 ,uM) ; (c) insulin (50 uU/ml) in the presence of epinephrine; or (d) insulin, epinephrine, and cytochalasin B. A set ofcontrol vials had no additions. Equilibrated adipocytes were added to bring the incubation volume to 1 ml. The incubations were ended after 30 min by the addition of 0.3 ml 2 N perchloric acid. The extract was transferred to centrifuge tubes, and the extracted protein was sedimented. The infranatant was removed and neutralized before assay for glycerol as described by Lowry et al. (14) .
The incorporation of [14C]histidine into protein was measured as previously described (13) . Equilibrated adipocytes were added to vials which contained 0.5 ,uCi [14C]histidine and the various agents being tested, to bring the final volume to 1 ml. After 30 min of incubation at 37°C, aliquots were I Abbreviations used in this paper: BSA, bovine serum albumin; Fm-I, monomeric ferritin-insulin; PBS-BSA, phosphate-buffered saline containing 0.1% BSA.
removed from the vials to 2.54-cm squares of Whatman filter paper (Whatman, Inc., Clifton, N. J.). The protein was precipitated by immersing the filter papers in cold, 10% TCA following the procedure of Mans and Novelli (15) as modified for adipocytes (13) . The filters were air dried, then placed in liquid scintillation vials containing 15 ml toluene-Omnifluor (New England Nuclear, Boston, Mass.) and counted in a liquid scintillation counter.
The effect of cytochalasin B on insulin binding was determined by incubating 105 cells/ml for 15 min at 37°C with 0-20,M cytochalasin B. 1251-labeled insulin (50 ,tU/ml, 0.6 ACi) was then added to the cells, and the incubation continued for 15 min at 37°C. The cell suspensions were diluted with 5 ml cold 0.1 M phosphate-buffered saline containing 0.1% BSA (PBS-BSA) and decanted onto Whatman GF/C glass fiber filters (Whatman, Inc.). The filters were washed under moderate vacuum with 10 ml of the PBS-BSA buffer. Nonspecific binding of the labeled ligand was determined in the presence of 5 ,g/ml of porcine insulin, andl the vatlues reported are the corrected or specific binding.
The effect of cytochalasin B or D on basal andl insulinstimulated glucose oxidation was determined by adding 5 x 104 cells to vials that contained various concentrations of the cytochalasin from 0 to 20 AM in a final volume of 2 ml.
After 15 min at 37°C, 50 or 500 ,uIJ insulin/ml was added to the appropriate vials and D-[1-14C]glucose (0.55 mM) was added to all vials. The vials were immediately capped. At the end of 60 min at 37°C, '4CO2 was determined as described by Gliemann (16) . For protective effect studies, cells were incubated for 15 min at 370C with 250 ,uU insulin/ml before cytochalasin B and D-[1-_4C]glucose addition.
Transport of [2-14C] deoxyglucose and [3-O-3H]methylglucose was determined under similar conditions except that the final incubation volume was 0.25 ml, the sugar concentration was 0.1 mM, and the incubation time after addition of the ra(lioactive sugar was either 10 min for 2-deoxyglucose or 10 s for 3-O-methylglucose. The incubation was terminated by diluting the cell suspension with 3 ml PBS-BSA and decanting the cells onto a Whatman GF/C filter. The filter was washed once with 10 ml PBS-BSA, air dried, and counted for "4C or 3H in a liquid scintillation counter.
Morphological studies. Monomeric ferritin-insulin (Fm-I) wats prepared and characterized as previously described (6) . The monomeric peak of ferritin was purified on a Bio-Gel A 1.5 MI chromatographic columiin (Bio-Racd Laboratories, Richmond, Calif.). The monomeric ferritin was conjugated to insulin with dilute glutaraldehyde that specifically reacts with lysine residues and does not cross-link ferritin (4-6), which makes the B-29 lysine of insulin the point of crosslinking. The resulting conjugate was repurified on Bio-Gel A 1.5 M, revealing only Fm-I, which confirmied the lack of cross-linking of ferritin by glutaraldehyde. The Fm-I peak was concentrated by centrifugation at 150,000 g for 2 h, and the pellet was resuspended in 0.1 M NaPO4 buffer (pH 7.4) and stored at 4°C. The biological and immunological activity ofthe conjugate were assessed by comnparison with the original porcine insulin. These activities were equal to each other and revealed that only about 2% of the ferritin contained insulill as previously reported (4) (5) (6) , which indicated that only one insulin would be present on one ferritin. Thus, any ferritin core bound to the cells would represent an insulin receptor. The actual Fm-I used in this study was the same as that previously used (6) .
Adipocytes were incubated with Fm-I under conditions essentially identical to the biochemical studies. About 106 cells were incubated with various concenitrations of cytochalasini B or D for 15 min at 37°C before the addition of 500 ,LU Fmn-I/ ml. For protective effect studies, the cells were incubated 572
L. Jarett and R. M. Smith for 15 min at 37°C with 500 ,AU Fm-I/imil before adding cytochalasin B or D. The cells were then incubated for 30 min at 37°C. The suspension was diluted with cold PBS-BSA and centrifuged at 800g, and the infranatant was aspirated. The cells were prepared for electron microscopy as previously described in detail (5) . Only areas of cells showing ferritin cores were photographed. As previously reported, the adipocyte has -10() ferritin-insulini receptors per square micron of plasma membrane (3). It wvas not feasible, therefore, to photograph entirely at random the entire cell surface in any given section. The validity of the qualitative and quantitative results presented below was assured by careful and strict adherence to several principles and methodological approaches. First, the sectionied specimens were numerically coded in such a manner that the microscopist was unaware of the experimental condition being observed. The entire cell surface of all cells in a given section was careftillv observed, and all ferritin cores were photographed. A minimium of 100 micrographs (x33,000) were taken of each experimental condition at a uniform magnification. The negatives were printed to yield a final magnification of90,000. The distribution of the ferritin-inisulin receptors into groups of variousi sizes were characterized by the proximity of the ferritin cores to each other (Fig. 7 [6] ). This was determined independenitlv by at least two personis who were also unaware of the experimental condition being ainalyzed. The data was tabulated, and the results presented represent the mnean of all determinationis for a given experimental condition in up to five experiments. Controls for electron microscopy were performed as previously described (4-6) and includled (a) Fm-I plus 5 Ag/ml of porcine insulin and (b) the same amount of ferritin as present in the Fm-I. In neither case wvas more than a few cellassociated ferritin cores seen in multiple sections from multiple blocks as previously reported (4-6), which indicated the almost complete absence of nonspecific binding. There are several reasons for this extremely low nonspecific level coompared with the nonspecific binding reported in Fig. 1 
RESULTS
Biochemnical studies. The effect of cvtochalasin B was tested on various metabolic pathways th<at are insulin sensitive. Cvtochalasin B had Ino effect on basal or epinephrine-(0.125 /ug/mnl) stimulated lipolvsis of the adipocvte (data not showiv) as reported previously bv Loten and jeainrenaud (11) . Insulin (50 ,uU/ml) inhibited epinephrine-stiimiulatedl lipolysis to the same extent in the presence or absenice of cytochalasin B. The insulin concentration was chosen to give a submlaximial inhibition of the lipolysis so that ainy minior from the control at each concentrattion of cytochalasin B. Nonspecific binding was determined in the presence of 5 ug insulin/ml. Cytochalasin B had no effect on nonspecific binding, which aecountedl for <20% of totall binding.
effect of cvtochalasin B would be found aind not prevente(l bvy a supermiiaximiial insulini coneenitrattionl.
Cvtochalasini B at 5 ANI had negligil)le effect on protein svnthesis of the adipocyte (Table I ). Insulini at 50 and 100 ()tU/ml produced a 47 and 88% stimulation of adipoeyte protein synthesis as meeasured 1yI[14C]histidine incorporation into protein. C tochalasin B had no effect on the ability of insuliin to stimulate protein sy,,nthesis.
The effect of cvtochalasin B on insulin biinding to a(lipocytes was determined because it had been reporte(l that a 2-h incubation of INI-9 lymphocytes with high concenitrations (> 2 g.I) of cytochalasin B caused significaint jnhibition of subseqluenit insulini binding to the cells (17) . Fig. 1 shows that exposure of adipocytes to a range of cvtochalasin B conieentrationis (0. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ftM\I) for 15 min, followed by 1251-insulin (50 ,uU/ml) resulted in ac smiiall but progressive inierease in the aimounit of insulin bound with inereasinig cytochalasin Table II show that cytochalasin B inhibited basal glucose transport in a progressive fashion reaching maximal at 5 uM. Addition of cytochalasin B before the addition of 50 ,uU insulin/ ml resulted in an identical pattern of inhibition of insulin-stimulated glucose oxidation. Examination of these data by comparing the insulin-stimulated level of glucose transport in the presence of cytochalasin B with the level at each comparable cytochalasin B concentration revealed that insulin stimulated the glucose transport by the same percent regardless of the presence or absence of cytochalasin B (Table II) . The slightly greater stimulation at the 5-uM cytochalasin B concentration reflects the difficulty in accurately measuring the low level of basal glucose oxidation. These data suggested that cytochalasin B acted only Qn the basal glucose transport system and did not interfere with the ability of insulin to stimulate the remaining uninhibited basal activity. Fig. 2 demonstrates the ability of insulin to partially protect against the cytochalasin B inhibition of glucose oxidation. If cells were preincubated with 50 nM-5 ,uM of cytochalasin B, a progressive inhibition was found of the insulin-(250 ,uU/ml) stimulated glucose oxidation. Pretreatment of adipocytes with insulin followed by the addition of cytochalasin B partially protected the glucose oxidation system from inhibition. Over a log greater concentration of cytochalasin B was needed to demonstrate inhibition of the insulinstimulated glucose oxidation if insulin was added first compared with cytochalasin B. This insulin effect was found to be dose dependent, with lower concentrations of insulin less effective (data not shown). Separate studies were performed measuring the effect of 1 ,uM Fig. 3 showed that an increase in concentrations of cytochalasin B caused a progressive increase in the number of single receptors and a decrease in the number of larger groups of insulin receptors. The RECEPTOR SITES PER GROUP FIGURE 3 The effect of cytochalasin B on the distribution of Fm-I receptors on adipocytes was determined by incubating adipocytes in the absence or presence of the indicated concentrations of cytochalasin B for 15 min at 37°C before the addition of 500 ,uU/ml Fm-I. After 30 min at 37°C, the cells were washed and prepared for electron microscopic observation. The distribution of the Fm-I receptors was analyzed as detailed in Methods. The results depicted represent a typical experiment, showing the percentage of the total receptors observed in each group size of from one to six receptor sites per group. after treatment with 20 ,uM cytochalasin B. The decrease in the number of groups with three or four receptors was obvious. The number of receptors in groups oftwo appeared to be relatively consistent. This probably does not indicate that groups of two were not disrupted, because as the disruption of the larger group occurred, more groups with two receptor molecules would be formed. Thus, the most reliable index of disruption of the groups would be the percent increase in single receptors.
The similarity in the concentrations of cytochalasin B required for inhibition of glucose transport (Table II) and for disruption of the groups of insulin receptors (Figs. 3 and 4) suggested a possible relationship between these two phenomena. A separate set of studies was performed in which morphological observations were carried out with one portion of an adipocyte preparation with 500 ,uU Fm-I/ml, while the rest of the cells were used for the biochemical measurements of glucose oxidation with 500 ,uU insulin/mil. These data are presented in Fig. 5 . A significant correlation (r = 0.964, P < 0.001) was found between the ability of cytochalasin B to inhibit glucose transport (as determined by glucose oxidation) and to disrupt the groups of insulin receptors (as determined by measurement of the percent increase in single receptors above control levels).
The ability of Fm-I to protect the groups of insulin receptors against disruption by cytochalasin B was tested, as insulin preincubation of cells was found to protect against the cytochalasin B inhibition of glucose oxidation (Fig. 2) . Addition of Fm-I before the addition of cytochalasin B did partially protect the groups of insulin receptors from disruption (Fig. 6 ), similar to the biochemical studies.
Cytochalasin B is known to have at least two major effects on cells: inhibition of glucose transport (10) and alteration of cellular cytoskeletal elements, such The effect of cytochalasin B on glucose oxidation and the distribution of Fm-I receptors was determined when a single preparation of adipocytes was divided into two sets of cells. One set was used to determine the effectiveness of cytochalasin B in inhibiting glucose oxidation in the presence of 500 ,U insulin/ml; the other set was used to determine the distribution of insulin receptors after cytochalasin B treatment. Cytochalasin B concentrations were 0.1-20 ,uM, and the details of incubation and analytical procedures are described in Methods. The data was plotted to illustrate the percent change between cells incubated with 500 ,SU insulin or Fm-I per milliliter in the absence of cytochalasin B and cells incubated with each concentration of cytochalasin B for both analyzed parameters.
as microfilaments and actin (18) . Cytochalasin D does not inhibit glucose transport (19) but does alter microfilaments at even lower concentrations than cytochalasin B (20) . Thus, the effects of cytochalasin D on the groups of insulin receptors was tested. Fig. 7 shows that cytochalasin D had no effect on the distribution of the groups of insulin receptors on the adipocyte surface, just as it had no effect on glucose oxidation by the adipocyte.
DISCUSSION
Previous ultrastructural studies have shown that insulin receptors are present in randomly distributed groups associated with the glycocalyx coating of the adipocyte plasma membrane (3) (4) (5) (6) . Data in one ofthese reports suggested that the groups are present before, and independent of, occupancy by the ligand (6), which indicated that the receptors are not randomly distributed. Similar groups of insulin receptors have been found on microvilli of human placental syncytial trophoblasts (21) . Naturally occurring groups of melano-* cyte-stimulating hormone receptors have also been reported (22) . The questions to be addressed in this study concern whether the groups of insulin receptors were / necessary for insulin action, and what physiological function these groups might have. * Cytochalasin B was capable of markedly altering the distribution pattern of insulin receptors in groups of various sizes. The most obvious effect of cytochalasin B was to increase the number of single insulin receptor molecules and decrease the groups of three to four (Figs. 2 and 3) . This disruption or alteration in receptor grouping occurred without affecting the action of insulin on membrane-related or intracellular processes. The biochemical data confirmed the findings of Loten and Jeanrenaud (11) that cytochalasin B had no effect on the antilipolytic effect of insulin. In addition, cytochalasin B had no effect on insulin stimula- One aliquot of adipocytes served as the control and was incubated with 500 ,uU Fm-I/ml for 30 min at 37°C (0). A second aliquot was incubated with 500 ,uU Fm-I/ml for 15 min before the addition of 5 AM cytochalasin B (Cyto B).
These cells were incubated an additional 15 min at 37°C (-). A third aliquot was incubated with 5 AM cytochalasin B for 15 min before adding 500 ,U Fm-I/ml and incubating for an additional 30 tion of protein synthesis. Cytochalasin B was capable of inhibiting the basal glucose transport system, and thereby prevented insulin from stimulating the disrupted basal system. However, any remaining uninhibited basal glucose transport was responsive to insulin to the same extent as in the absence of any cytochalasin B. This is consistent with the data ofCzech et al. (10) . Thus, it would appear that maximum disruption of the groups of insulin receptors by cytochalasin B did not interfere with insulin action. At least three explanations exist for this. First, and most likely, the glycoproteins to which insulin binds contain the mechanism for initiating insulin action and can function whether part of a group or not. The second is that not all of the groups are disrupted, and the remaining ones can account for maintaining insulin action through spare receptors (23, 24) ; however, concentrations of cytochalasin B that caused maximal disruption of receptor groups did not alter the actions of insulin at submaximal concentrations of insulin (making this explanation unlikely). A third possibility is that there are two functionally distinct types of groups of insulin receptors: one group is sensitive to cytochalasin B and relates to glucose transport as discussed below; and the second type of group is insensitive to, and not disrupted by, cytochalasin B and may account for all other actions of insulin.
The data in this study would suggest that the groups (30) , the erythrocyte band 3 anion transport protein (31) , the bacteriorhodopsin in the purple membranes which transport H+ ions (32), rhodopsin (33), the Ca++-ATPase of sarcoplasmic reticulum (34) , and the acetylcholine receptor (35) (39) , which shows that anti-insulin receptor antibodies have a similar magnitude of effect as insulin on 2-deoxyglucose uptake and glycolysis, but a smaller effect on glycogen synthesis than insulin, all in skeletal muscle. Caution must be exercised at this time in the interpretation of the antibody data as to its implications to the mechanism of insulin action. The actin or actin-myosin cytoskeletal system would not appear to be involved in the mechanism of insulin action or in holding the groups of insulin receptors together. Both cytochalasin B and D disrupt microfilaments (18, 40) and interfere with actin gelation (9, 41) , with cytochalasin D even more effective than cytochalasin B. The concentrations of cytochalasin B used in this study were at the lower level of effective concentrations that disrupt microfilaments or interfere with actin gelatin in other cell systems studied. In contrast, the cytochalasin D levels were at the high end of the effective range. Cytochalasin B has a unique binding site not shared with cytochalasin D, which has been related to the glucose transport glycoprotein system (19) . Cytochalasin B, but not cytochalasin D, inhibited glucose transport and disrupted insulin receptor groups. Thus, the disruption of the groups of insulin receptors concomnitant with the inhibition of glucose transport suggests that the disruption relates to the mechanism by which cytochalasin B inhibits glucose transport rather than any action on microfilaments or actin gelation. The mechanism by which cytochalasin B inhibits glucose transport is not known, but has been suggested (42) to be because of competitive binding with glucose on the glucose transport glycoprotein as a result of an identical spatial distribution of four oxygen atoms to those found in the Cl conformiation of 8-D-glucopyranose. These biochemical and morphological observations should provide a test system for further study into the mechanism by which insulin and cytochalasin B act on the glucose transport system.
